CB
Coherus BioSciences Inc
🇩🇪XSTU.8C5GermanyHealthcare
€1.15EURdown -0.05 (-4.17%)OpenEnd of day5:44 PM
Price€1.15-0.05 (-4.17%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US19249H1032
- CUSIP
- Not reported
Company
- Employees
- 144
- Headquarters
- Redwood City, United States
- Website
- https://www.coherus.com
- CEO
- Mr. Dennis M. Lanfear
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- -$0.85
- P/E LTM
- -1.69
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $50.94M-64.32%down year on year
- Net income
- -$130.96M+17.82%up year on year
- Gross margin
- 63.55%+13.33%up year on year
- Free cash flow
- -$243.92M-130.4%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.